-+ 0.00%
-+ 0.00%
-+ 0.00%

Processa Pharma CEO George Ng acquires 2,129 common shares for $5,471.53

PUBT·06/01/2026 20:59:36
Listen to the news
Processa Pharma CEO George Ng acquires 2,129 common shares for $5,471.53
  • Processa Pharmaceuticals CEO George K. Ng bought 2,129 common shares at USD 2.57, lifting his direct stake to 9,970 shares.
  • He also reported 4,288 shares held indirectly through an IRA account and a family trust.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000897069-26-001291), on June 01, 2026, and is solely responsible for the information contained therein.